We use cookies to help provide you with the best possible online experience. Please read our Privacy Policy for information about which cookies we use and what information we collect on our site. By continuing to use this site, you agree that we may store and access cookies on your device.
The market size of the global hypoglycemic drugs exceeded USD 40 billion in 2017, which became the second largest drug market next only to the oncology drug market.